Articles On Volpara Health Technologies (ASX:VHT)

Australian health stocks sightly up for the week with optimistism of a traditional end-of-year rally In positive news several healthcare names deliver strong quarterly results and forecasts Morgans upgrades Nanonosonics from Hold to Add an...

Times of uncertainty are unsettling to live through. However, they do create very interesting chances to buy discounted ASX growth shares. Higher interest rates have had a strong impact on the share prices of businesses that are expected to...

ASX tech shares have taken a big hit in 2022. Plenty of them are down 50% or more this year. I think this could be one of the best times to invest in technology. For the last few years, many technology businesses have had sky-high valuation...

Volpara Health Technologies (VHT) promotes its CEO to the role of Managing DirectorThe company’s current Chief Executive Officer Teri Thomas has taken on the role of Managing Director, which became effective from October 1The incoming Manag...

I think there are plenty of ASX growth shares that now look good value after a hefty market dislocation in 2022. When interest rates go up it can have the effect of lowering share prices because the risk-free rate that investors can get fro...

I’m always on the lookout for interesting ASX growth shares that may be able to achieve good returns over the long-term. Businesses that can achieve good compound growth can become much larger over the long-term, which hopefully translates...

I think that reporting season can be a catalyst to go hunting for ASX shares. August is a good month to find hidden opportunities. Some share prices are up and some share prices are down. I think that there are some great-looking businesses...

ShareCafeGlobal Biotech Turnaround Looks to Be Underway Signs of life are emerging in the global biotech sector, after the longest and sharpest downturn in history that was so severe it left hundreds US companies trading below cash backing....

The world is moving toward a subscription economy We take a look at the most important metrics for a SaaS company Which ASX stocks top the list of recurring revenue earners The world is moving towards a subscription economy. Think Netflix...

I think there are a few ASX shares that have been hit hard during 2022 that may be long-term opportunities at these prices. It’s certainly possible that a handful of businesses may have seen their share prices fall too hard. When things ar...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. The health sector falls sligh...

It’s quarterlies season as the ASX market announcements page becomes increasingly flooded with lodgements. The last day for companies to submit reports is the last business day of the first month after the prior quarter. If they don’t, they...

The Volpara Health Technologies Ltd (ASX: VHT) share price is rising today after the company released its quarterly results. The company’s shares lifted 13% in earlier trade before retreating. The Volpara share price is now up 4.65%, trad...

The Volpara Health Technologies (ASX: VHT) share price jumped 6% today after the company released two important updates to the market: its quarterly cash flow report, and findings from CEO Teri Thomas’ strategic review. Volpara’s review con...

Volpara Health Technologies (ASX:VHT) has announced the completion of the strategic review undertaken by CEO Teri Thomas and the executive management team.

MoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We’ll tap our extensive list of experts to hear what’s hot, their top picks, and what they’re looking out for. Today we hear from Pac Partners...

It has been a volatile year for some of the ASX’s leading growth shares. Since the start of 2022, many names known for quickly growing revenue have seen share price declines. I wouldn’t say that every single thing that has fallen is an...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in ASX health stocks. ASX health stocks get much needed July rally aft...

Lower share prices make better buying for ASX tech shares in my opinion. It’s a pretty obvious statement, but I think it’s this time that will prove to be a good time for long-term buying. While higher interest rates are meant to hurt share...

ShareCafeEvening Report: 4 July, 2022 by Lauren Evans   The Australian sharemarket had a strong start to the week after all sectors finished Monday’s session in positive territory. Energy led the pack, up 2.6 per cent, followed by real esta...

Today, the Volpara Health Technologies Ltd (ASX: VHT) share price leapt 21% higher after announcing it secured a roll-out of Volpara Risk Pathways and Volpara Analytics to the 350+ sites owned or operated by Radnet Inc (NASDAQ: RDNT). Volpa...

The ASX 200 and XEC small cap indices rise Attention turns to Tuesday’s date with RBA destiny Celsius Resources is hot   The ASX 200 and the Emerging Markets (XEC) indices are both trading higher on Monday up about 1.2%, ahead of tomorrow...

04 July 2022 - Volpara Health Technologies (ASX:VHT) has signed a 42-month contract with Radnet Management, with a mutual option to extend.

Highlights Shares of Volpara were trading with a gain of over 15% on Monday morning Volpara has signed a volume-based contract with a US-based company, RadNet Management Under the agreement, RadNet will employ Volpara® Analytics™ and...

ShareCafeLunch Report: 4 July, 2022 by Lauren Evans   The Australian sharemarket has jumped this morning in a broad-rally led by property, then communication services, healthcare and utilities. At noon, the S&P/ASX 200 is 1.1 per cent o...

The All Ordinaries Index (ASX: XAO) has broken into the green and trades 1.1% higher in morning trade on Monday. Indeed, with a new month comes a new set of monthly returns. After some volatility in recent weeks, investors look to embark o...

HitIQ and Volpara sign major deals in the US ECS Botanics makes first cannabis flower shipment to NZ Invex to commence Phase III study in Australia Following its extension contract with New Zealand Rugby a couple of weeks ago, HitIQ (ASX:...

Volpara Health Technologies (VHT) signs a contract with US-based RadNet Management for the use of Volpara’s imaging and mammography software Under the contract, RadNet will implement the Volpara Analytics and Volpara Risk Pathways software...

The Aussie market is poised to open 1.5% higher this morning Iron ore slips by 4% on Friday The RBA will make its interest rates decision on Tuesday The Aussie sharemarket is poised to follow Wall Street higher at the open, with the ASX 2...

I think the current investment environment is looking like a good time to go hunting for ASX growth shares for the long-term with $3,000. Companies that are growing their revenue and operations at a decent pace could be good businesses to...

Volpara Health Technologies (ASX:VHT) has announced a new research and development collaboration with Microsoft to accelerate the creation of a product that detects and quantifies breast arterial calcifications.

Avita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is popular for athletes and sports teams PainChek’s smartphone app can tell if babies or older Aussies are in pain There’s a plethora of biotech...

Highlights The shares of ASX-listed technology stocks Xero Limited, WiseTech Global Limited, and Computershare Ltd. remained on investors’ radar today. The S&P/ASX 200 Information Technology (Sector) XIJ was up 0.990% at 1295.100 p...

Highlights ASX 200 was up 0.90% at 6,491.30 points in the initial few minutes of trading today. The shares of four ASX-listed Graphite stocks, Novonix Limited, Renascor Resources Limited, Syrah Resources Limited, and Magnis Energy Tech...

I’m putting money to work after all of the ASX share market difficulties in recent months. It’s not easy investing at a time like this. It might feel like trying to catch a falling knife. In other words, investments in June could drop in va...

ASX healthcare stocks finish the week modestly in the green Lumos and Audeara rattle the tin in a bid to raise more capital EOFY sell downs puts more pressure on ailing health stocks Healthcare and life sciences expert Scott Power, who ha...

Iron ore, lithium and manganese miner Mineral Resources added to the S&P/ASX 50 Index Ailing investment manager Magellan Investment Financial Group dropped out of the S&P/ASX 100 Index The S&P/ASX All Technology Index sees only...

ASX healthcare index finishes another week in the red Enterprise imaging stocks tipped to be a first recovery The goliath battle for fertility company Virtus comes to an end Healthcare and life sciences expert Scott Power – a senior analy...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

There are a handful of ASX shares that I think would make excellent buys to hold for the long term. Companies with long-term growth plans and large potential markets can generally produce good compound returns over the coming years, in my...

Dark clouds continue to hover over ASX health stocks Health imaging company Volpara’s FY22 results in line with expectations Fight for fertility company Virtus enters another round Healthcare and life sciences expert Scott Power – a senio...

Highlights ASX 200 didn’t sustain morning cheers, closed 0.69% lower on weak Chinese growth cues. Top performer was information technology sector, up 1.09%, with Appen (ASX:APX) as top gainer. Appen, Virtus Health, Westpac, were newsm...

Shares in Volpara Health Technologies Ltd (ASX: VHT) jumped out of the gates on Thursday and are now trading 2% higher at 75 cents. Investors are bidding up the Volpara share price following the release of the company’s full-year results...

There is a group of ASX-listed companies that has delivered a lot of financial growth in recent times, yet the share prices of those businesses have dropped heavily in 2022. A business may not necessarily be better value if it has fallen a...

There has been so much volatility on the ASX share market this year. I’m seeing chances to invest. Low prices don’t normally stay low forever. Normally, like we last saw in 2020, most share prices go back up eventually. All of these impacts...

If the Melbourne-based, US-focused radiology digital imaging house is running out of steam after an enormous five years of growth, co-founder and CEO Dr Sam Hupert isn’t letting on. These days the company – Pro Medicus (ASX:PME) commands a...

The deep sell down of the US biotech sector has resulted in the valuation of many of the ASX-listed life science plays looking a tad sickly, too. Arguably, many of them were overvalued in the first place. But in many cases the companies ar...

Experts currently have a very favourable opinion about some impressive ASX shares. May 2022 could be the month to jump on some of these stocks. Businesses that are growing revenue and profit at a double-digit rate could be opportunities af...

The ASX healthcare sector rebounds on back of $20 billion Ramsay Healthcare takeover bid Volpara founder and CEO steps into new role as female CEO takes the reins Medlab Clinical shares soar after UK trade deal for probiotic for patients...

The Australian life sciences sector hasn’t had a good run in the past year. While the S&P/ASX 200 is up ~8%, the S&P/ASX 200 healthcare index has fallen ~2%.  However, Morgans senior analyst from the healthcare team Scott Power is c...